Discover
TDOC
Teladoc Health, Inc.
9.10
800 x undefined
2000 x undefined
bid
ask
+
0.62
7.31%
1400 @ 06:02 AM
9.05 -0.05 (0.55%)
| Ytd | 30.00% | |
| 1y | 6.06% |
8.57
day range
9.14
4.40
52 week range
9.77
| Open | 8.59 | Prev Close | 8.48 | Low | 8.57 | High | 9.14 | Mkt Cap | 1.64B |
| Vol | 5.08M | Avg Vol | 4.74M | EPS | -0.97 | P/E | N/A | Forward P/E | -13.12 |
| Beta | 2.14 | Short Ratio | 7.10 | Inst. Own | 84.07% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 7.03 | 200-d Avg | 6.81 | 1yr Est | 7.40 |
| Income Statement | |||
| Total Revenue | 613.85M | ||
| Revenues (USD) | 613.85M | ||
| Cost of Revenue | 197.53M | ||
| Gross Profit | 416.32M | ||
| Operating Expenses | 478.09M | ||
| Research and Development Expense | 67.86M | ||
| Selling, General and Administrative Expense | 304.90M | ||
| Operating Income | -61.77M | ||
| Interest Expense | 5.37M | ||
| Income Tax Expense | 3.00M | ||
| Net Income | -63.84M | ||
| Net Income Common Stock | -63.84M | ||
| Net Income Common Stock (USD) | -63.84M | ||
| Consolidated Income | -63.84M | ||
| Earnings per Basic Share | -0.36 | ||
| Earnings per Basic Share (USD) | -0.36 | ||
| Earnings per Diluted Share | -0.36 | ||
| Earning Before Interest & Taxes (EBIT) | -55.47M | ||
| Earning Before Interest & Taxes (USD) | -55.47M | ||
| Weighted Average Shares | 179.12M | ||
| Weighted Average Shares Diluted | 179.12M | ||
| Balance Sheet | |||
| Cash and Equivalents | 750.74M | ||
| Cash and Equivalents (USD) | 750.74M | ||
| Trade and Non-Trade Receivables | 213.63M | ||
| Current Assets | 1.13B | ||
| Property, Plant & Equipment Net | 50.51M | ||
| Total Assets | 2.81B | ||
| Total Debt | 1.03B | ||
| Current Liabilities | 404.87M | ||
| Debt Non-Current | 1.03B | ||
| Total Liabilities | 1.47B | ||
| Accumulated Retained Earnings (Deficit) | -16.49B | ||
| Accumulated Other Comprehensive Income | -35.42M | ||
| Shareholders Equity | 1.34B | ||
| Shareholders Equity (USD) | 1.34B | ||
| Assets Non-Current | 1.67B | ||
| Total Debt (USD) | 1.03B | ||
| Deferred Revenue | 76.08M | ||
| Goodwill and Intangible Assets | 1.52B | ||
| Inventory | 31.56M | ||
| Liabilities Non-Current | 1.07B | ||
| Trade and Non-Trade Payables | 45.20M | ||
| Tax Liabilities | 27.61M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 94.19M | ||
| Net Cash Flow from Financing | -2.45M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -29.45M | ||
| Capital Expenditure | -35.82M | ||
| Issuance (Purchase) of Equity Shares | 399.00K | ||
| Net Cash Flow from Investing | -36.52M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -700.00K | ||
| Net Cash Flow from Operations | 9.52M | ||
| Effect of Exchange Rate Changes on Cash | -891.00K | ||
| Share Based Compensation | 14.61M | ||